This cohort study examines the association of overall survival with endocrine therapy to treat hormone receptor–positive, ERBB2-negative breast cancer.
No takes yet. Share an insight, caveat, or question.
Jun et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: